2021
DOI: 10.1016/j.ejphar.2021.174337
|View full text |Cite
|
Sign up to set email alerts
|

Luteolin mitigates tamoxifen-associated fatty liver and cognitive impairment in rats by modulating beta-catenin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 33 publications
0
7
0
Order By: Relevance
“…In particular, pHPEA-EDA was shown to be able to selectively block cyclooxygenases [ 31 ], demonstrating that, together with inflammatory transcription factors, kinases and cytokines are also present in antimutagenic and anticancer downstream pathways of gallic, caffeic and coumaric acids, verbascoside and pinoresinol [ 32 , 33 , 34 , 35 , 36 ]. Using cell models, the anticancer activities of apigenin and luteolin have been linked to the microRNA-dependent downregulation of E2F1/3 transcription factors [ 37 ], and the use of rats confirmed luteolin’s properties in limiting the adverse effects of antitumorals [ 38 , 39 ]. Free radical scavenging or pro-apoptotic properties and ferulic, vanillic, syringic and 3,4-dihydroxybenzoic acids were demonstrated by in vitro studies [ 29 , 40 ], while animal models showed that restoration properties (e.g., on gut microbiota or asthma) by these molecules involved the modulation of several inflammation parameters and pro-inflammatory cytokines [ 41 , 42 , 43 ].…”
Section: Origin and Functions Of Phenolic Compoundsmentioning
confidence: 99%
“…In particular, pHPEA-EDA was shown to be able to selectively block cyclooxygenases [ 31 ], demonstrating that, together with inflammatory transcription factors, kinases and cytokines are also present in antimutagenic and anticancer downstream pathways of gallic, caffeic and coumaric acids, verbascoside and pinoresinol [ 32 , 33 , 34 , 35 , 36 ]. Using cell models, the anticancer activities of apigenin and luteolin have been linked to the microRNA-dependent downregulation of E2F1/3 transcription factors [ 37 ], and the use of rats confirmed luteolin’s properties in limiting the adverse effects of antitumorals [ 38 , 39 ]. Free radical scavenging or pro-apoptotic properties and ferulic, vanillic, syringic and 3,4-dihydroxybenzoic acids were demonstrated by in vitro studies [ 29 , 40 ], while animal models showed that restoration properties (e.g., on gut microbiota or asthma) by these molecules involved the modulation of several inflammation parameters and pro-inflammatory cytokines [ 41 , 42 , 43 ].…”
Section: Origin and Functions Of Phenolic Compoundsmentioning
confidence: 99%
“…El‐Asfar et al reported that LUT co‐treatment with TAM significantly enhanced spatial learning and memory impairment and reduced cortex and hippocampal neuronal degeneration. LUT also decreased hepatotoxicity resulting from exposure to TAM in experimental models which was expressed by diminishing levels of serum triacylglycerol (TAG), AST, and ALT 88 . LUT has also been reported to reduce inflammatory factors, such as IL‐1β, TNF‐α, and hepatic TGF‐β levels which play a major role in the development of fatty livers.…”
Section: Lut Against Drug Toxicitymentioning
confidence: 97%
“…These authors found that LUT reduced hepatic β‐catenin levels resulting from fatty liver progression following TAM exposure. LUT may improve TAM‐induced cognitive impairment and fatty liver and also have a protective effect against neurodegeneration resulting from TAM exposure 88 …”
Section: Lut Against Drug Toxicitymentioning
confidence: 99%
“…The rats were divided into six groups (12 in each group) as follows: 1) sham operated group (sham); 2) MCAO/R (vehicle) group, rats underwent MCAO/R and were then orally treated with 0.9% sterile saline for 7 days at beginning of reperfusion; 3) luteolin-25 group, rats underwent MCAO/R and were then orally treated with 25 mg/kg/d luteolin (MFCD00017309, Macklin, Shanghai, China) dissolved in 0.9% sterile saline (w/v) for 7 days at beginning of reperfusion [19,20]; 4) luteolin-50 group, rats underwent MCAO/R and were then orally treated with 50 mg/kg/d luteolin dissolved in 0.9% sterile saline (w/v) for 7 days at beginning of reperfusion [19,20]; 5) pioglitazone group, rats underwent MCAO/R and were then orally treated with 10 mg/kg/d PPARγ agonist pioglitazone (HY-13956, MedChemExpress, Shanghai, China) [21] dissolved in 0.9% saline for 7 days at beginning of reperfusion; 6) luteolin-50 + T0070907 group, rats underwent MCAO/R and were then orally treated with 50 mg/kg/d luteolin combined with 10 mg/kg/d PPARγ inhibitor T0070907 (HY-13202, MedChemExpress, Shanghai, China) [21] dissolved in 0.9% saline for 7 days at beginning of reperfusion.…”
Section: Experimental Groupsmentioning
confidence: 99%
“…After washing with 0.9% saline, the brain was frozen at − 20 °C for 10 min. Then, the brain tissue was cut into 6 sections, and soaked in 1% TTC solution (20,190,917, Solarbio, China) at room temperature for 15 min without light. The coronal slices were photographed and analyzed by Image J software (National Institutes of health, USA).…”
Section: 35-triphenyltet-razolium Chloride (Ttc) Stainingmentioning
confidence: 99%